Tissue-Specific Chk1 Activation Determines Apoptosis by Regulating the Balance of p53 and p21
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (031A309)
This publication has 55 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell linesBMC Cancer, 2013
- A Decade of Advances in Treatment of Early-Stage Lung CancerClinics in Chest Medicine, 2011
- Variations in Mre11/Rad50/Nbs1 status and DNA damage-induced S-phase arrest in the cell lines of the NCI60 panelBMC Cancer, 2011
- Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behaviorBMC Cancer, 2011
- Two-phase dynamics of p53 in the DNA damage responseProceedings of the National Academy of Sciences, 2011
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Recurrent Initiation: A Mechanism for Triggering p53 Pulses in Response to DNA DamageMolecular Cell, 2008
- Cancer risks among BRCA1 and BRCA2 mutation carriersBritish Journal of Cancer, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006